The Mouse Monoclonal anti-MERS-Coronavirus Spike antibody has been validated for ELISA and WB. It is suitable to detect MERS-Coronavirus Spike in samples from Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Catalog No. ABIN7596097
Quick Overview for MERS-Coronavirus Spike antibody (RBD) (ABIN7596097)
Target
MERS-Coronavirus Spike (MERS-CoV S)
(MERS-Coronavirus Spike Protein (MERS-CoV S))
Reactivity
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Host
Mouse
Clonality
Monoclonal
Conjugate
This MERS-Coronavirus Spike antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Clone
AT2F7
Binding Specificity
RBD
Purpose
MERS-CoV Spike RBD antibody
Purification
protein-A affinity chromatography
Immunogen
Recombinant MERS-CoV Spike RBD (358-606aa) purified from Baculovirus
MERS-CoV S
Reactivity: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
ELISA, FACS, Neut, SPR
Host: Human
Monoclonal
7D10
unconjugated
Recombinant Antibody
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% glycero
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
Target
MERS-Coronavirus Spike (MERS-CoV S)
(MERS-Coronavirus Spike Protein (MERS-CoV S))
Alternative Name
MERS-CoV Spike
Background
MERS-CoV, which causes the Middles East Respiratory Syndrome (MERS), belongs to a family of viruses known as coronaviruses. MERS-CoV was first identified in the Kingdom of Saudi Arabia in 2012, which is a single and positive stranded RNA virus. Dromedary camels are widely considered as the source of the transmission of MERS-CoV. The rate of human transmission among household contacts of MERS patients has been approximately 5 % based on serological analysis. MERS-CoV has four structural proteins, known as the S (spike), E (envelope), M (membrane), and N (nucleocapsid) proteins. The spike protein, responsible for allowing the virus to attach to and fuse with the membrane of a host cell and is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. MERS-CoV S mediates viral attachment and fusion to human cells via human cellular receptor DPP4, also known as CD26. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.